Testing effectiveness (Phase 2)Not Yet RecruitingNCT07177703
What this trial is testing
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension
Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Shanghai Zhongshan Hospital 32